Home > Specialties > IVD Test Reagent/Kits, Serology, Virus, Epidemic Parotitis (Mumps), IgG Antibody

IVD Test Reagent/Kits, Serology, Virus, Epidemic Parotitis (Mumps), IgG Antibody

Definition : Serology reagents intended to detect immunoglobulin G (IgG) antibodies to epidemic parotitis (mumps) virus, an RNA virus of the genus Paramyxovirus, family Paramyxoviridae. This virus is the etiologic agent of epidemic parotitis (also known as mumps), an infection characterized by swelling of one or both parotid glands that may also affect the pancreas, cause inflammation of the testes (orchitis), and affect the ovaries.

Entry Terms : "Reagents, Serology, Virus, Epidemic Parotitis (Mumps), IgG Antibody"

UMDC code : 22380

Filters
Manufacturers
Distributors
U.S.companies only
Suppress Subsidiary Companies
   

1-6 of 6 Match(es).

Awareness Technology Inc

Company Type: Parent

We invite you to discover Awareness Technology's ChemWell, ChemWell-T, Stat Fax, LumiStat, and ChroMate instruments. Now, more than ever before, the discerning laboratorian is inclined to seek versatile, economical alternatives to more expensive labo

Bion Enterprises Ltd

Company Type: Parent

MBL International Corporation is a leading life science company focused on providing high quality products and solutions for life science research and clinical diagnostics.

Block Scientific Inc

Company Type: Parent

Mayo Medical Laboratories

Company Type: Parent

Sterling Diagnostics Inc

Company Type: Parent

Sterling Diagnostics develops and manufactures clinical diagnostic reagents and supplies. We offer a full line of laboratory equipment and supplies to support you.

Zeus Scientific Inc

Company Type: Parent

ZEUS Scientific is a privately held corporation that was founded in 1976. The company began producing IFA (immunofluorescence assay) test systems followed ELISA and now multiplex (AtheNA Multi-Lyte) immunoassays. New products are developed to expand the menu which allows laboratories to run an increasing number of assays with common protocols and common reagents, as well as developing new tests to more accurately diagnose patients. In 1987 ZEUS Scientific was the first company to develop, receive appropriate regulatory clearance and bring to market a serological assay to test for Lyme disease – a condition with high prevalence in the local community where ZEUS Scientific is located.

1-6 of 6 Match(es).